New endocrine agents for the treatment of breast cancer.
Department of Medical Oncology, Charing Cross Hospital, London, UK.
R C
RC
Coombes
M
M
Jarman
M
M
Dowsett
S K
SK
Chander
M G
MG
Rowlands
E
E
Di Salle
T J
TJ
Evans
D000818:Animals; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D013429:Sulfatases / Q000037:antagonists & inhibitors; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000627:therapeutic use; D014407:Tumor Cells, Cultured / Q000187:drug effects
D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D013629:Tamoxifen; C071362:idoxifene; D013429:Sulfatases; C020121:estrone sulfatase